Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients

Autor: Fabrice Bonnet, A. Gautier, Ariane Godbout, Mathieu Coudert, Gilles Brassier, Catherine Grosheny, Laurent Riffaud, Philippe Touraine, Christian Sainte-Rose, Marc de Kerdanet, Carine Courtillot, Christel Jublanc, Elisabeth Thibaud, Isabelle Tejedor, Jean-Yves Poirier, Remy Van Effenterre
Přispěvatelé: Foie, métabolismes et cancer, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Service d'endocrinologie diabétologie et nutrition [Rennes], Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-CHU Pontchaillou [Rennes]-Hôpital Anne-de-Bretagne, Endocrinology Division, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM)-Université de Montréal (UdeM)-Department of Medicine, CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Pierre et Marie Curie - Paris 6 (UPMC), Modeling in Clinical Research, Université Pierre et Marie Curie - Paris 6 (UPMC)-EA 3974, Service de Pédiatrie, Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Service de neurochirurgie [Rennes] = Neurosurgery [Rennes], CHU Pontchaillou [Rennes], Service de neurochirurgie pédiatrique [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Craniopharyngioma Study Group, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Université de Rennes (UR)-CHU Pontchaillou [Rennes]-Hôpital Anne-de-Bretagne, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -CHU Pontchaillou [Rennes]-Hôpital Anne-de-Bretagne, Centre de recherche du Centre Hospitalier de l'Université de Montréal ( CRCHUM ) -Department of Medicine, Department of Endocrinology and Reproductive Medicine, CHU Pitié-Salpêtrière [APHP]-Centre de Référence des Maladies Endocriniennes rares de la croissance et des maladies gynécologiques rares, Université Pierre et Marie Curie - Paris 6 ( UPMC ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -EA 3974, Department of Biostatistics and Medical Informatics, CHU Pitié-Salpêtrière [APHP], Department of Endocrinology and Metabolism, Service de neurochirurgie [Rennes], Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Department of Neurosurgery, Le Corre, Morgane
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Male
Pediatrics
MESH : Retrospective Studies
Endocrinology
Diabetes and Metabolism

Clinical Biochemistry
MESH : Child
Preschool

Biochemistry
MESH: Craniopharyngioma
Cohort Studies
Craniopharyngioma
0302 clinical medicine
Endocrinology
MESH : Child
Quality of life
MESH: Child
MESH : Female
MESH : Craniotomy
[ SDV.IB ] Life Sciences [q-bio]/Bioengineering
Age of Onset
Child
MESH: Cohort Studies
[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
MESH : Prognosis
MESH: Middle Aged
MESH : Neoplasm Recurrence
Local

MESH: Follow-Up Studies
MESH : Adult
[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
Middle Aged
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
Prognosis
MESH : Age of Onset
3. Good health
030220 oncology & carcinogenesis
Child
Preschool

MESH: Survival Analysis
MESH : Social Adjustment
Female
[SDV.IB]Life Sciences [q-bio]/Bioengineering
France
Social Adjustment
MESH: Neoplasm Recurrence
Local

Craniotomy
Cohort study
MESH: Intracranial Hypertension
Adult
medicine.medical_specialty
Adolescent
MESH : Male
MESH: Age of Onset
MESH: Craniotomy
MESH : Cohort Studies
Context (language use)
MESH: Prognosis
03 medical and health sciences
MESH : Intracranial Hypertension
MESH : Adolescent
Internal medicine
MESH : Craniopharyngioma
medicine
Humans
MESH : Middle Aged
MESH : France
Survival rate
Survival analysis
Retrospective Studies
[SDV.IB] Life Sciences [q-bio]/Bioengineering
MESH: Adolescent
MESH: Humans
business.industry
MESH : Humans
Biochemistry (medical)
MESH: Child
Preschool

MESH: Quality of Life
MESH : Follow-Up Studies
Retrospective cohort study
MESH: Adult
MESH: Retrospective Studies
MESH : Quality of Life
medicine.disease
Survival Analysis
MESH: Social Adjustment
MESH: Male
Surgery
MESH: France
Quality of Life
MESH : Survival Analysis
Age of onset
Intracranial Hypertension
Neoplasm Recurrence
Local

business
MESH: Female
030217 neurology & neurosurgery
Follow-Up Studies
Zdroj: Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2012, 97 (4), pp.1258-67. ⟨10.1210/jc.2011-2817⟩
Journal of Clinical Endocrinology and Metabolism, 2012, 97 (4), pp.1258-67. ⟨10.1210/jc.2011-2817⟩
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2012, 97 (4), pp.1258-67. 〈10.1210/jc.2011-2817〉
ISSN: 0021-972X
1945-7197
DOI: 10.1210/jc.2011-2817⟩
Popis: International audience; CONTEXT: Craniopharyngiomas are often associated with an unfavorable prognosis, but data on their long-term consequences are sparse. OBJECTIVE: The aim of the study was to identify markers of recurrence and factors associated with compromised social rehabilitation and altered quality of life in a large cohort of patients with either childhood-onset (CO) or adult-onset craniopharyngioma. METHODS: Retrospective analysis was performed for 171 patients treated for craniopharyngioma in two academic centers in France between 1972 and 2009. For each subject, data were collected concerning clinical presentation, imaging features, visual sequelae, endocrine and metabolic impact, treatment modalities (surgery, radiotherapy), recurrence-free survival rate, and social insertion, as well as answers to the WHO-QOL BREF questionnaire. RESULTS: A total of 65 CO and 106 adult-onset patients were reviewed. If CO was diagnosed before the age of 10 yr, this was associated with a higher incidence of obesity, blindness, and panhypopituitarism, and only 40.7% of subjects had adequate work or school attendance compared to 72.4% of patients with later disease onset. Initial symptoms of intracranial hypertension (SIHT), pterional surgery, and multiple surgery were associated with obesity and poorer social insertion. No determinant of quality of life was identified. In the subgroup of patients treated in the 1990s and later, the progression rate was 59.4% in patients with residual tumor on magnetic resonance imaging compared with a 19.8% recurrence rate in the group with apparently complete resection. Recurrence/progression correlates significantly with male gender, early onset (before 10 yr), and SIHT, but only SIHT at presentation remained a significant predictor with multivariate analysis. CONCLUSIONS: Craniopharyngioma continues to be associated with severe outcomes. Higher morbidity rates are found in patients with early-onset disease (before 10 yr), initial SIHT, or in whom pterional surgery was required. Markers of recurrence are difficult to identify, with SIHT being the most powerful predictor.
Databáze: OpenAIRE